518 related articles for article (PubMed ID: 29582940)
1. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
3. Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
Harrison BR; Peters BG; Bing MR
Am J Health Syst Pharm; 2006 Sep; 63(18):1736-44. PubMed ID: 16960258
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
5. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
Villa A; Molimard M; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
BMJ Open; 2019 Nov; 9(11):e033040. PubMed ID: 31712349
[TBL] [Abstract][Full Text] [Related]
7. Occupational exposure to antineoplastic drugs in four Italian health care settings.
Sottani C; Porro B; Imbriani M; Minoia C
Toxicol Lett; 2012 Aug; 213(1):107-15. PubMed ID: 21477641
[TBL] [Abstract][Full Text] [Related]
8. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.
Sessink PJ; Connor TH; Jorgenson JA; Tyler TG
J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.
Ursini CL; Cavallo D; Colombi A; Giglio M; Marinaccio A; Iavicoli S
Int Arch Occup Environ Health; 2006 Nov; 80(2):134-40. PubMed ID: 16761155
[TBL] [Abstract][Full Text] [Related]
11. Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process.
Valero S; López-Briz E; Vila N; Solana A; Melero M; Poveda JL
Regul Toxicol Pharmacol; 2018 Jun; 95():1-7. PubMed ID: 29510165
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture for chronic hepatitis B.
Kong Z; Liang N; Yang GL; Zhang Z; Liu Y; Yang Y; Liu YX; Wang QG; Zhang F; Zhang HY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013107. PubMed ID: 31436846
[TBL] [Abstract][Full Text] [Related]
13. Wound infiltration with local anaesthetic agents for laparoscopic cholecystectomy.
Loizides S; Gurusamy KS; Nagendran M; Rossi M; Guerrini GP; Davidson BR
Cochrane Database Syst Rev; 2014 Mar; (3):CD007049. PubMed ID: 24619479
[TBL] [Abstract][Full Text] [Related]
14. Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel.
Reddy VK; Lavoie MC; Verbeek JH; Pahwa M
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009740. PubMed ID: 29190036
[TBL] [Abstract][Full Text] [Related]
15. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
Verbeek JH; Ijaz S; Mischke C; Ruotsalainen JH; Mäkelä E; Neuvonen K; Edmond MB; Sauni R; Kilinc Balci FS; Mihalache RC
Cochrane Database Syst Rev; 2016 Apr; 4():CD011621. PubMed ID: 27093058
[TBL] [Abstract][Full Text] [Related]
16. Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011647. PubMed ID: 28273330
[TBL] [Abstract][Full Text] [Related]
17. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
Siderov J; Kirsa S; McLauchlan R
J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture for symptomatic gastroparesis.
Kim KH; Lee MS; Choi TY; Kim TH
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009676. PubMed ID: 30560568
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
